Suchergebnisse - "Yang, Jinliang"

PubPharm (81)

1

Heritable microbiome variation is correlated with source environment in locally adapted maize varieties

enthalten in: Nature plants | 2024

von He, X. | Wang, D. | Jiang, Y. | +24

2

Unraveling Prevalence and Effects of Deleterious Mutations in Maize Elite Lines across Decades of Modern Breeding

enthalten in: Molecular biology and evolution | 2023

von Sun, S. | Wang, B. | Li, C. | +6

3

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers

enthalten in: Molecular cancer therapeutics | 2023

von Zhou, W. | Fang, P. | Yu, D. | +24

4

Hybrid allele-specific ChIP-seq analysis identifies variation in brassinosteroid-responsive transcription factor binding linked to traits in maize

enthalten in: Genome biology | 2023

von Hartwig, T. | Banf, M. | Prietsch, G. | +10

5

Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis

enthalten in: Biochemical and biophysical research communications | 2023

von Lu, Y. | Wang, M. | Zhao, M. | +12

6

Estimating the genetic parameters of yield-related traits under different nitrogen conditions in maize

enthalten in: Genetics | 2023

von Palali Delen, S. | Xu, G. | Velazquez-Perfecto, J. | +1

7

CD25 : A potential tumor therapeutic target

enthalten in: International journal of cancer | 2023

von Peng, Y. | Tao, Y. | Zhang, Y. | +3

8

A common resequencing-based genetic marker data set for global maize diversity

enthalten in: The Plant journal : for cell and molecular biology | 2023

von Grzybowski, M. | Mural, R. | Xu, G. | +3

CommentIn: Plant J. 2023 Mar;113(6):1107-1108. - PMID 36920972

9

DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis

enthalten in: Frontiers in immunology | 2023

von Wu, Y. | Li, W. | Chen, X. | +10

10

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma

enthalten in: Journal of hematology & oncology | 2022

von Zhang, G. | Guo, C. | Wang, Y. | +30

1
2
3
4
5
6
7
8
9
Nächster »
[9]